Company / Return on Equity (ROE)
AtriCure, Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-2.3%
FY2025
5-year range
-10.2% / 10.4%
FY2021-FY2025
Trend
+76.0%
vs FY2024
Sector context
#92 of 147
Health Care
What the data says
AtriCure, Inc. reports negative total equity of -2.3% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-2.3% in FY2025 with a 5-year CAGR of +9.3%.
Improved from -6.5% to -2.3% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +7.8pp
- 5-Year Change
- +9.3pp
- 10-Year Change
- -
Sector benchmark
#92 of 147 in Health CareTop 63% of 147This company -2.3% Sector average -3.1%
▼
+25.3% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 76.0% year-over-year.
- Currently 0.8pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2016.
Company context
Key Data Points
- Negative profit margin: -9.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -2.3% | +76.0% |
| FY2024 | -9.7% | -48.5% |
| FY2023 | -6.5% | +35.8% |
| FY2022 | -10.2% | -198.0% |
| FY2021 | 10.4% | +188.9% |
| FY2020 | -11.7% | +17.9% |
| FY2019 | -14.2% | -67.8% |
| FY2018 | -8.5% | +49.2% |
| FY2017 | -16.7% | +15.7% |
| FY2016 | -19.8% | -35.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026